News
Topical BRAF inhibitor LUT014 gel significantly reduces acneiform rash from anti-EGFR therapies in patients with colorectal ...
Zevaskyn, which Abeona priced at $3.1 million, treats epidermolysis bullosa. It will compete with a gene therapy from Krystal ...
George Warren, PhD, Lead Author and Principal Scientist at Artelo, said, “We are excited to share the results on this novel target in psoriasis. Our findings demonstrate that ART26.12 has effects ...
Artelo Biosciences advances ART26.12 for psoriasis and CIPN, while ART27.13 shows early promise in cancer-related anorexia ...
6d
Fashionista on MSNMore Beauty Brands Are Investing in Third-Party Certifications — Is it Worth it?Brands like Tilt Beauty, Seen and Tower 28 are marketing their products with special seals of approval. Here's how they get ...
Itchy breasts can be caused by a number of health issues. Learn what they are and how to effectively treat them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results